Infinity Pharmaceuti (INFI) |
|
1.17 0.01 (0.86%)
|
08-13 16:00 |
|
Open: |
1.15 |
Pre. Close: |
1.16 |
|
High:
|
1.18 |
Low:
|
1.09 |
|
Volume:
|
819,582 |
Market Cap:
|
69M |
|
|
|
|
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. It offers IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the enzyme phosphoinositide-3-kinase-gamma Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib, as well as duvelisib program for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma; and PellePharm, Inc. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.181 - 1.186 |
1.186 - 1.192 |
|
Low:
|
1.076 - 1.083 |
1.083 - 1.088 |
|
Close:
|
1.159 - 1.17 |
1.17 - 1.179 |
|
Technical analysis |
as of: 2020-08-13 4:35:23 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 1.45  One year: 1.69 |
| Support: |
Support1: 0.96 Support2: 0.78 |
| Resistance: |
Resistance1: 1.24 Resistance2: 1.45 |
| Pivot: |
0.97  |
| Moving Average: |
MA(5): 1.11 MA(20): 0.94
MA(100): 0.94 MA(250): 1.06 |
| MACD: |
MACD(12,26): 0.06 Signal(9): 0.03 |
| Stochastic oscillator: |
%K(14,3): 82.54 %D(3): 83.68 |
| RSI: |
RSI(14): 72.05 |
| 52-week: |
High: 1.68 Low: 0.60 Change(%): -4.1 |
| Average Vol(K): |
3-Month: 73811 10-Days: 106269 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.INFI has closed below upper band by 9.3%. Bollinger Bands are 102.9% wider than normal. The large width of the bands suggest high volatility as compared to INFI's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 12 Aug 2020
Stocks To Watch: Infinity Pharmaceuticals, Inc. (INFI) Is Creating Trading Opportunities - Invest Million
Wed, 12 Aug 2020
The Forecast Just Changed on Infinity Pharmaceuticals Inc. (NASDAQ:INFI) - The Oracle Dispatch
Tue, 11 Aug 2020
An in-depth look at the Infinity Pharmaceuticals, Inc. (INFI) stock - Marketing Sentinel
Tue, 11 Aug 2020
How Much Is Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Paying Its CEO? - Yahoo Finance
Tue, 11 Aug 2020
Infinity Pharmaceuticals (NASDAQ:INFI) Will Have To Spend Its Cash Wisely - Yahoo Finance
Thu, 06 Aug 2020
How Much Is Infinity Pharmaceuticals’ (NASDAQ:INFI) CEO Getting Paid? - Simply Wall St
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
57 |
| Shares Float (M) |
38 |
|
% Held by Insiders
|
3.51 |
|
% Held by Institutions
|
50.64 |
|
Shares Short (K)
|
47 |
|
Shares Short P. Month (K)
|
36 |
Stock Financials |
|
EPS
|
-0.774 |
|
EPS Est This Year
|
-0.920 |
|
EPS Est Next Year
|
-1.500 |
|
Book Value (p.s.)
|
-0.040 |
|
Profit Margin
|
|
|
Operating Margin
|
-3174.61 |
|
Return on Assets (ttm)
|
-40.2 |
|
Return on Equity (ttm)
|
-237.9 |
|
Qtrly Rev. Growth
|
-80.0 |
|
Gross Profit (p.s.)
|
-0.546 |
|
Sales Per Share
|
0.023 |
|
EBITDA (p.s.)
|
-0.732 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-38 |
|
Levered Free Cash Flow (M)
|
-27 |
Stock Valuations |
|
PE Ratio
|
-1.51 |
|
PEG Ratio
|
|
|
Price to Book value
|
-29.25 |
|
Price to Sales
|
50.52 |
|
Price to Cash Flow
|
-1.79 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
